Literature DB >> 18170982

Determination of carryover and contamination for mass spectrometry-based chromatographic assays.

Nicola C Hughes1, Ernest Y K Wong, Juan Fan, Navgeet Bajaj.   

Abstract

The Third American Association of Pharmaceutical Scientists/Food and Drug Administration Bioanalytical Workshop, held in 2006, reviewed and evaluated current practices and proposed that carryover and contamination be assessed not only during the validation of an assay but also during the application of the method in a study. In this article, the potential risks of carryover and contamination in each stage of a bioanalytical method are discussed, to explain to the industry why this recommendation is being made.

Mesh:

Year:  2007        PMID: 18170982      PMCID: PMC2751487          DOI: 10.1208/aapsj0903042

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  8 in total

1.  The persistent memory effect of triethylamine in the analysis of phospholipids by liquid chromatography/mass spectrometry.

Authors:  H Rütters; T Möhring; J Rullkötter; J Griep-Raming; J O Metzger
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

2.  Evaluation of a four-channel multiplexed electrospray triple quadrupole mass spectrometer for the simultaneous validation of LC/MS/MS methods in four different preclinical matrixes.

Authors:  L Yang; T D Mann; D Little; N Wu; R P Clement; P J Rudewicz
Journal:  Anal Chem       Date:  2001-04-15       Impact factor: 6.986

3.  Demonstration of direct bioanalysis of drugs in plasma using nanoelectrospray infusion from a silicon chip coupled with tandem mass spectrometry.

Authors:  Jean-Marie Dethy; Bradley L Ackermann; Claude Delatour; Jack D Henion; Gary A Schultz
Journal:  Anal Chem       Date:  2003-02-15       Impact factor: 6.986

4.  A novel approach for in-process monitoring and managing cross-contamination in a high-throughput high-performance liquid chromatography assay with tandem mass spectrometric detection.

Authors:  Min S Chang; Elaine J Kim; Tawakol A El-Shourbagy
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

5.  Evaluation of 384-well formatted sample preparation technologies for regulated bioanalysis.

Authors:  Min S Chang; Elaine J Kim; Tawakol A El-Shourbagy
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

6.  Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

Authors:  C T Viswanathan; Surendra Bansal; Brian Booth; Anthony J DeStefano; Mark J Rose; Jeffrey Sailstad; Vinod P Shah; Jerome P Skelly; Patrick G Swann; Russell Weiner
Journal:  Pharm Res       Date:  2007-04-26       Impact factor: 4.200

7.  Determination of MK-0431 in human plasma using high turbulence liquid chromatography online extraction and tandem mass spectrometry.

Authors:  Wei Zeng; Donald G Musson; Alison L Fisher; Amy Qiu Wang
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

8.  Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.

Authors:  Enaksha R Wickremsinhe; Bradley L Ackermann; Ajai K Chaudhary
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

  8 in total
  12 in total

1.  Comparative study of traditional flagellum serotyping and liquid chromatography-tandem mass spectrometry-based flagellum typing with clinical Escherichia coli isolates.

Authors:  Keding Cheng; Angela Sloan; Lorea Peterson; Stuart McCorrister; Alyssia Robinson; Matthew Walker; Tracy Drew; Joanne McCrea; Linda Chui; John Wylie; Sadjia Bekal; Aleisha Reimer; Garrett Westmacott; Mike Drebot; Celine Nadon; J David Knox; Gehua Wang
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

2.  Scoring Large-Scale Affinity Purification Mass Spectrometry Datasets with MiST.

Authors:  Erik Verschueren; John Von Dollen; Peter Cimermancic; Natali Gulbahce; Andrej Sali; Nevan J Krogan
Journal:  Curr Protoc Bioinformatics       Date:  2015-03-09

3.  False EX1 signatures caused by sample carryover during HX MS analyses.

Authors:  Jing Fang; Kasper D Rand; Penny J Beuning; John R Engen
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

4.  Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors.

Authors:  Birgit G Bradel-Tretheway; Jonelle L Mattiacio; Alexei Krasnoselsky; Catherine Stevenson; David Purdy; Stephen Dewhurst; Michael G Katze
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Toward implementation of quorum sensing autoinducers as biomarkers for infectious disease states.

Authors:  Anjali K Struss; Ashlee Nunes; Jill Waalen; Colin A Lowery; Prasanna Pullanikat; Judith R Denery; Douglas J Conrad; Gunnar F Kaufmann; Kim D Janda
Journal:  Anal Chem       Date:  2013-02-26       Impact factor: 6.986

Review 6.  Steroid assays in paediatric endocrinology.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-02-01

7.  Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method.

Authors:  Narasimha M Midde; Mohammad A Rahman; Chetan Rathi; Junhao Li; Bernd Meibohm; Weihua Li; Santosh Kumar
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

8.  Determination of rivaroxaban in patient's plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS).

Authors:  Priscilla Bento Matos Derogis; Livia Rentas Sanches; Valdir Fernandes de Aranda; Marjorie Paris Colombini; Cristóvão Luis Pitangueira Mangueira; Marcelo Katz; Adriana Caschera Leme Faulhaber; Claudio Ernesto Albers Mendes; Carlos Eduardo Dos Santos Ferreira; Carolina Nunes França; João Carlos de Campos Guerra
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

9.  Monitoring of system conditioning after blank injections in untargeted UPLC-MS metabolomic analysis.

Authors:  Teresa Martínez-Sena; Giovanna Luongo; Daniel Sanjuan-Herráez; José V Castell; Máximo Vento; Guillermo Quintás; Julia Kuligowski
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

Review 10.  Inferring Protein-Protein Interaction Networks From Mass Spectrometry-Based Proteomic Approaches: A Mini-Review.

Authors:  Kumar Yugandhar; Shagun Gupta; Haiyuan Yu
Journal:  Comput Struct Biotechnol J       Date:  2019-06-20       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.